Product Adoption Programs
Communicating the appropriate uses of therapy can be inaccurately characterized as "losing patients" and therefore "losing money." In fact, supporting appropriate use, done the right way, should have a positive net effect on the bottom line.
ParagonRx appropriate use programs are grounded in firsthand medical practice in order to create greater physician mastery, improved patient care and more confident product utilization.
Value drivers supported by these programs include:
- Product salvage. Some compounds on which development was discontinued can be revisited given robust appropriate use programs.
- Priority review and fast-track approval. Appropriate use programs can help gain early market access for a narrow indication with barriers to broader use. It can also support new labeling when clinical benefit has not yet been established.
- Prescriber confidence-building. Clinicians concerned with a product's risks are more comfortable prescribing it when they have access to tools that mitigate risk.
ParagonRx programs add value to your new, emerging or mature product. As the right patients benefit from the right treatment at the right time, the therapy's success drives its durable commercial potential to help patients.
Previous page: Patient Care Process Mapping
